Practical guidelines for the long-term treatment of psoriasis with efalizumab

Journal of the American Academy of Dermatology

Volumn 54, Issue 4 SUPPL., 2006, Pages

  Leonardi, Craig L ^a,d   Papp, Kim A ^b   Bos, Jan D ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Probity Medical   (Canada)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Central Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; EFALIZUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; LONG TERM CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE; TREATMENT WITHDRAWAL;

EID: 32544448638     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.12.017     Document Type: Article

References (1)

1. M. Lebwohl New developments in the treatment of psoriasis Arch Dermatol 138 2002 686 688